- Investing Ideas
- /
- Vietnamese Pharmaceuticals & Biotech Potentially Undervalued Companies
Vietnamese Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
4
0 new
Companies with a Value score of at least 3, ordered by Value score
4 companies
Central Pharmaceutical No3
Market Cap: ₫1.2t
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
DP3
₫54,100.00
7D
0.4%
1Y
-12.0%
Phong Phu Pharmaceutical
Market Cap: ₫188.3b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
PPP
₫21,400.00
7D
7.0%
1Y
24.4%
SPM
Market Cap: ₫158.4b
Manufactures and sells pharmaceutical products and lease assets in Vietnam.
SPM
₫11,500.00
7D
4.5%
1Y
0%
Cai Lay Veterinary Pharmaceutical
Market Cap: ₫52.0b
Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina.
MKV
₫10,400.00
7D
7.2%
1Y
14.3%